We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,633 results
  1. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development

    Pulmonary arterial hypertension (PAH) is a multifactorial disease associated with the remodeling of pulmonary blood vessels. If left unaddressed, PAH...

    Jaydev Dave, Vineeta Jagana, ... Malik Bisserier in Journal of Translational Medicine
    Article Open access 17 July 2023
  2. USP15 promotes pulmonary vascular remodeling in pulmonary hypertension in a YAP1/TAZ-dependent manner

    Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disease characterized by pulmonary vascular remodeling. Excessive growth and...

    Zhuhua Wu, Li Zhu, ... Yong Qi in Experimental & Molecular Medicine
    Article Open access 12 January 2023
  3. A novel complement C3 inhibitor CP40-KK protects against experimental pulmonary arterial hypertension via an inflammasome NLRP3 associated pathway

    Background

    Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary disease characterized by complement dependent and proinflammatory...

    Lei Dai, Yu Chen, ... **aodan Zhong in Journal of Translational Medicine
    Article Open access 16 February 2024
  4. Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling

    High expression of the zinc finger X-chromosomal protein (ZFX) correlates with proliferation, aggressiveness, and development in many types of...

    Ling Tang, **ao Zhou, ... Silin Pan in Cardiovascular Toxicology
    Article 03 February 2024
  5. Nets, pulmonary arterial hypertension, and thrombo-inflammation

    Abstract

    Pulmonary arterial hypertension (PAH) is a progressive and fatal vascular disease in which high blood pressure in the pulmonary artery and...

    Luís Pedro Baptista de Barros Ribeiro Dourado, Mário Santos, Daniel Moreira-Gonçalves in Journal of Molecular Medicine
    Article 20 April 2022
  6. The Sugen/Hypoxia Rat Model for Pulmonary Hypertension and Right Heart Failure

    Pulmonary hypertension (PH) is a devastating disease, characterized by complex remodeling of the pulmonary vasculature. PH is classified into five...
    Olympia Bikou, Yassine Sassi in Experimental Models of Cardiovascular Diseases
    Protocol 2024
  7. Administration of A. muciniphila ameliorates pulmonary arterial hypertension by targeting miR-208a-3p/NOVA1 axis

    Pulmonary arterial hypertension (PH) is a chronic disease induced by a progressive increase in pulmonary vascular resistance and failure of the right...

    Zheng-yi Bao, Hui-min Li, ... Lan-juan Li in Acta Pharmacologica Sinica
    Article 11 July 2023
  8. In Vitro Experimental Approach for Studying Human Pulmonary Artery Smooth Muscle Cells and Endothelial Cells Proliferation and Migration

    Pulmonary arterial hypertension (PAH) is a severe vascular disease characterized by persistent precapillary pulmonary hypertension, leading to right...
    Seun Imani, Roslyn Wallace, Yassine Sassi in Experimental Models of Cardiovascular Diseases
    Protocol 2024
  9. A new integrative analysis of histopathology and single cell RNA-seq reveals the CCL5 mediated T and NK cell interaction with vascular cells in idiopathic pulmonary arterial hypertension

    Background

    Inflammation and dysregulated immunity play vital roles in idiopathic pulmonary arterial hypertension (IPAH), while the mechanisms that...

    **ncheng Li, Shuangshuang Ma, ... Zhenguo Zhai in Journal of Translational Medicine
    Article Open access 26 May 2024
  10. Pulmonary Hypertension

    The progressive and devastating disorder of pulmonary hypertension is associated with vascular remodelling and vascular rarefaction. This escalates...
    Sudipto Saha, Sreyashi Majumdar, Parthasarathi Bhattacharyya in Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases
    Chapter 2023
  11. LncRNA MIR210HG promotes phenotype switching of pulmonary arterial smooth muscle cells through autophagy-dependent ferroptosis pathway

    Hypoxic pulmonary hypertension (HPH) is a pathophysiological syndrome in which pulmonary vascular pressure increases under hypoxic stimulation and...

    Enze Wang, Binbin Zhang, ... Ran Wang in Apoptosis
    Article 18 April 2024
  12. Pulmonary Vasoreactivity

    Pulmonary circulation is characterized by low intravascular arterial pressure and low vascular resistance. As compared with those of systemic...
    Chapter 2022
  13. Obstructive sleep apnea-increased DEC1 regulates systemic inflammation and oxidative stress that promotes development of pulmonary arterial hypertension

    Obstructive sleep apnea (OSA), characterized by chronic intermittent hypoxia (CIH), is a common risk factor for pulmonary arterial hypertension...

    **aoming Li, **ang Zhang, ... Ming **a in Apoptosis
    Article 09 December 2022
  14. P53 in Vascular Remodeling: The Potential for Targeting in Atherosclerosis

    Purpose

    At first, p53 was believed to be present primarily in malignant cells. In fact, p53 turned out to play a major role in vascular remodeling...

    Anastasia V. Poznyak, Elena B. Zhigmitova, ... Alexander N. Orekhov in Journal of Medical and Biological Engineering
    Article 17 June 2023
  15. Targeting Molecular and Cellular Mechanisms of Pulmonary Arterial Hypertension

    Pulmonary arterial hypertension (PAH) is a devastating disease of the pulmonary circulation, characterized by pulmonary vascular remodeling leading...
    Md Khadem Ali, Jay C. Horvat, Edda F. Spiekerkoetter in Targeting Cellular Signalling Pathways in Lung Diseases
    Chapter 2021
  16. Unilateral Lung Removal in Combination with Monocrotaline or SU5416 in Rodents: A Reliable Model to Mimic the Pathology of the Human Pulmonary Hypertension

    Pulmonary hypertension (PH) is a chronic and progressive disorder characterized by elevated mean pulmonary arterial pressure, pulmonary vascular...
    Michael G. Katz, Yoav Hadas, ... Efrat Eliyahu in Experimental Models of Cardiovascular Diseases
    Protocol 2024
  17. Cytokines, Chemokines, and Inflammation in Pulmonary Arterial Hypertension

    According to the World Symposium Pulmonary Hypertension (WSPH) classification, pulmonary hypertension (PH) is classified into five categories based...
    Shuxin Liang, Ankit A. Desai, ... Haiyang Tang in Lung Inflammation in Health and Disease, Volume I
    Chapter 2021
  18. PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis

    Hypoxia plays an important regulatory role in the vasculature to adjust blood flow to meet metabolic requirements. At the level of gene...

    Harri Elamaa, Mika Kaakinen, ... Lauri Eklund in Angiogenesis
    Article Open access 08 January 2022
  19. Inflammation in Pulmonary Arterial Hypertension

    Pulmonary artery hypertension (PAH) is a devastating cardiopulmonary disease characterized by vascular remodeling and obliteration of the...
    Chapter 2021
  20. The Beneficial Effect of the Blockade of Stim-Activated TRPC-ORAI Channels on Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia Is Independent of Oxidative Stress

    Obstructive sleep apnea (OSA), a sleep breathing disorder featured by chronic intermittent hypoxia (CIH), is associated with pulmonary hypertension...
    Rodrigo Iturriaga, Sebastián Castillo-Galán in Arterial Chemoreceptors
    Conference paper 2023
Did you find what you were looking for? Share feedback.